Noticias y vídeos - Inglés

Medtronic Expand URO U.S. clinical trial meets safety and effectiveness primary endpoints for Hugo™ robotic-assisted surgery system PR Newswire GALWAY, Ireland and LAS VEGAS, April 26, 2025 Largest multi-center prospective Investigational Device Exemption (IDE) study for multi-port robotic-assisted urologic surgery in the U.S. presented as a late-breaker at the American Urologic Association annual meeting Company confirms Hugo RAS system submission to the U.S. Food and Drug Administration...

'Fox & Friends' breaks down how a man in the Bronx was dragged along a street after a thief tried to nab his car. #foxnews #shorts ......

Johnson & Johnson's TAR-200 monotherapy achieves high disease-free survival of more than 80 percent in BCG-unresponsive, high-risk papillary NMIBC PR Newswire LAS VEGAS, April 26, 2025 First results from SunRISe-1 (Cohort 4) show strong disease-free survival rates across high-grade papillary tumors, demonstrating the potential for bladder preservation with 94 percent of patients avoiding radical cystectomy 95 percent progression-free survival rate at 9-months signals the promise of TAR-200 in...

Johnson & Johnson's TAR-200 monotherapy demonstrates highest complete response rate with sustained clinical benefits in patients with certain types of bladder cancer PR Newswire LAS VEGAS, April 26, 2025 Phase 2b SunRISe-1 study shows more than 82 percent of patients achieved complete response (CR) with more than half of responders remaining cancer-free at one year after CR Results reinforce potential of TAR-200 to transform outcomes for certain types of BCG-unresponsive, high-risk non-muscle...

Pope Francis has been laid to rest at his favorite basilica in Rome following a public funeral at the Vatican. Huge crowds and ......

New York, New York--(Newsfile Corp. - April 26, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Quantum Computing Inc. (NASDAQ: QUBT) between March 30, 2020 and January 15, 2025, both dates inclusive (the "Class Period"), of the important April 28, 2025 lead plaintiff deadline. SO WHAT: If you purchased Quantum Computing securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs...

Pfizer Inc. (NYSE: PFE) today announced results from the pivotal Phase 3 CREST trial of sasanlimab, an investigational anti-PD-1 monoclonal antibody (mAb), in combination with standard of care (SOC) Bacillus Calmette-Guérin (BCG) as induction therapy with or without maintenance in patients with BCG-naïve, high-risk non-muscle invasive bladder cancer (NMIBC). The trial met its primary endpoint of event-free survival (EFS) by investigator assessment, demonstrating a clinically meaningful and...

Saint Herblain (France), April 26, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that France’s national public health agency, the Haute Autorité de Santé (HAS), has updated its recommendation for use of Valneva’s single-dose chikungunya vaccine IXCHIQ ® for the prevention of disease caused by the chikungunya virus (CHIKV) following reports of serious adverse events (SAEs) in elderly people with comorbidities during the ongoing...

Hundreds of thousands gathered to pay their respects at the funeral of Pope Francis, as royals, world leaders, and cardinals ......

New York, New York--(Newsfile Corp. - April 26, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of e.l.f. Beauty, Inc. ("Elf") (NYSE: ELF) between November 1, 2023 and November 19, 2024, both dates inclusive (the "Class Period"), of the important May 5, 2025 lead plaintiff deadline. SO WHAT: If you purchased Elf securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a...

New York, New York--(Newsfile Corp. - April 26, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Maravai Lifesciences Holdings, Inc. (NASDAQ: MRVI) between August 7, 2024 and February 24, 2025, both dates inclusive (the "Class Period"), of the important May 5, 2025 lead plaintiff deadline. SO WHAT: If you purchased Maravai securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs...

Attorney General Pam Bondi joins 'America Reports' to react to the arrests of judges accused of obstructing immigration ......

Jay Woods, CMT has some major advice when it comes to your 401(k) in times of volatility. Catch his full conversation with ......

...

New York, New York--(Newsfile Corp. - April 26, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ready Capital Corporation (NYSE: RC) between November 7, 2024 and March 2, 2025, both dates inclusive (the "Class Period"), of the important May 5, 2025 lead plaintiff deadline. SO WHAT: If you purchased Ready Capital securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a...

SWKS Deadline: SWKS Investors with Losses in Excess of $100K Have Opportunity to Lead Skyworks Solutions, Inc. Securities Fraud Lawsuit PR Newswire NEW YORK, April 26, 2025 NEW YORK , April 26, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Skyworks Solutions, Inc. (NASDAQ: SWKS) between July 30, 2024 and February 5, 2025 , both dates inclusive (the "Class Period"), of the important May 5, 2025 lead plaintiff deadline. So what: If...

Latest news bulletin | April 26th – Evening Catch up with the most important stories from around Europe and beyond - latest news, ......

Sky's Anna Botting presents a special programme from Rome looking back at the key moments from the funeral of Pope Francis....

President Donald Trump speaks to the press about Elon Musk's role in the administration and the Department of Government ......

'Real Time' host Bill Maher chats with Piers Morgan about the use of the Hitler comparison. #foxnews #shorts #news #politics ......